Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. The Iterative Health Site Network is a premier network of 70+ clinical research sites across US and Europe accelerating the path to market for gastrointestinal (GI) and hepatology novel therapies. Our focus is on driving the success and growth of our partner sites by empowering them with tech-enabled services. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need. About the Role Corporate Development is a critical driver of Iterative Health’s (iH) long-term growth strategy. As transaction activity accelerates in 2026 and beyond, iH is expanding this function to deepen its presence across new therapeutic areas. As Director, Lead Generation – Cardiology, you will play a central role in expanding iH’s cardiovascular footprint by originating and advancing strategic partnerships with independent cardiology-focused clinical research sites, site networks, and management services organizations (MSOs). This role sits at the front end of iH’s M&A and partnership funnel and directly influences company-shaping growth decisions. You will report to the VP, Corporate Development and work closely with the iH Executive Team and functional leaders. This position offers significant exposure to senior leadership and the opportunity to materially shape iH’s cardiovascular growth strategy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
No Education Listed